Basic Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Feb 28, 2024; 30(8): 901-918
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.901
Table 1 Description of the datasets used in this study
Clinical characteristicsGSE14520
TCGA
Total (n = 210)%Total (n = 369)%
Age
< 6016980.4816845.53
≥ 604119.5220054.20
Unknown10.27
Gender
Female2612.3812032.52
Male18487.6224967.48
T stage
T117948.51
T29425.47
T38021.68
T4133.52
Unknown30.81
N stage
N025067.75
N141.08
Nx11430.89
Unknown10.27
M stage
M026471.55
M141.08
Mx10127.37
Stage
I9042.8616945.80
II7535.718623.31
III4320.488523.04
IV00.0051.36
Unknown20.95246.50
Status
Alive13061.9024165.31
Dead8038.1012834.69
Unknown00.00
HBV status
AVR-CC5224.76
CC15272.38
Unknown62.86
Table 2 Primers used in this study
GeneForwardReverse
Metadherin5′-CCAGGCTCCTTCATCAACTT-3′5′-AthAAGCAGCCACCAGAGATTG-3′
CD1335′-TGGATGCAGACCTTGACAACGT-3′5′-ATACCTGCTACGACAGTCGTGGT-3′
Nanog5′-AATACCTCAGCCTCCAGCAGATG-3′5′- TGCGTCACACCATTGCTATTCTTC -3′
Oct45′-CAGGAGGCATTGCTGATGAT-3′5′-GAAGGCTGGGGCTCATTT-3′
GAPDH5′-CAGGAGGCATTGCTGATGAT-3′5′- GAAGGCTGGGGCTCATTT -3′